CDC5L      CRISPR in HepG2      Batch: BGHcLV49

Experiment Information (Status: Sequenced)
BGHcLV49-15BGHcLV49-16
idx00
TRCN#_or_BGC#BGC#0000688BGC#0000688
shRNA_or_gRNA_sequenceGCCCGCTTGGCTAATACTCAGCCCGCTTGGCTAATACTCA
PAMGGGGGG
NameCDC5L_93CDC5L_93
Sample_IDBGHcLV49-15BGHcLV49-16
transduction_Date6/6/256/6/25
daysD6D6
RBP_nameCDC5LCDC5L
qPCR_result0.00.0
Ave_qPCR
RT-qPCR_primer-F
RT-qPCR_primer-R
protein_conc33653669
WB_result61.849.8
Ave_WB
WB_DONE_date6/17/25
MW92kd
IP
antibody_Cat#A301-681ALOT# 1
Antibody DCC IDENCAB386CPV
submitted_to_DCC_date
Rep1_TPM00
Rep2_TPM00
ActionReadyReady
Library_start_date
repeat_library
Note
ID98979898




Western Blot
RBP Antibody InfoPrimary-HepG2Secondary-HepG2Primary-K562Secondary-K562Primary-UBERONPrimary-Hela
CDC5LProduct_ID: A301-681A
Lot_ID: 1
Source: Bethyl Labs
Target Name: CDC5L-human		 CDC5L-hepg2-CRISPR-A301-681A-LICOR.png<br>Caption: Western blot following CRISPR against CDC5L in HepG2 whole cell lysate using CDC5L specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against CDC5L. CDC5L protein appears as the green arrow, Beta-actin serves as a control and appears in red arrow.
 Bethyl_A301-681A_1_CDC5L.png<br>Caption: IP-WB analysis of K562 whole cell lysate using the CDC5L specific antibody, A301-681A. Lanes 1 and 2 are 2.5% of five million whole cell lysate input and 50% of IP enrichment, respectively, using a normal IgG antibody. Lane 3 is 50% of IP enrichment from five million whole cell lysate using the CDC5L-specific antibody, A301-681A. The same antibody was used to detect protein levels via Western blot. This antibody passes preliminary validation and will be further pursued for secondary validation. *NOTE* Protein sizes are taken from Genecards.org and are only estimates based on sequence. Actual protein size may differ based on protein characteristics and electrophoresis method used.
 CDC5L-K562-CRISPR-A301-681A.png<br>Caption: Western blot following CRISPR against CDC5L in K562 whole cell lysate using CDC5L specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against CDC5L. CDC5L protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.




Experiment Status
BGHcLV49-15BGHcLV49-16
Sample_IDBGHcLV49-15BGHcLV49-16
Sample Name
Sample NameCDC5L-BGHcLV49-15CDC5L-BGHcLV49-16
RBPCDC5LCDC5L
Cell_LineHepG2HepG2
Exp UID
StatusSequencedSequenced
Status_date2025-10-302025-10-30
ProjectENCORE2ENCORE2
Note
ID1433414335




Library-Prep Information
BGHcLV49-15BGHcLV49-16
Sample #3132
Sample NameCDC5L-BGHcLV49-15CDC5L-BGHcLV49-16
Sample_Name_Alias
Index Well PositionA05B05
Index_tableIDT_UniqueDualIndex_96_V2IDT_UniqueDualIndex_96_V2
LibPrep_date2025-08-202025-08-20
Lib_IDLib-250820Lib-250820
Tecan_Location
Tecan
Tecan_date
Size_bp262264
Peak_Molarity99.8073.20
libSampleQC_DNA_Well
RIN
libSample_RNA_Well
SampleQC_methodTapeStation_2022TapeStation_2022
SampleQC_date2025-09-102025-09-10
Sample_IDBGHcLV49-15BGHcLV49-16
RBPCDC5LCDC5L
Batch_IDBGHcLV49BGHcLV49
WB_result61.80049.800
Library DescriptionTruSeq mRNATruSeq mRNA
Repeat_Library_Suffix
Lib_StatusSendToSequenceSendToSequence
ProjectENCORE2ENCORE2
ID47764777




Sequencing Information
BGHcLV49-15BGHcLV49-16
Sample_IDBGHcLV49-15BGHcLV49-16
Sample NameCDC5L-BGHcLV49-15CDC5L-BGHcLV49-16
Pool IDPool-250916Pool-250916
LocalServer_folder
total_reads00
total_aligned_reads00
unique_aligned_reads00
percent_uniqueAligned
correlation_replicates
spikein_reads00
percent_spikeins
original_ReadLength
QC_StatusReadyToQCReadyToQC
ID35033504




Data Submission Information
DCC submission information was not avaliable




File Information
Files of the experiment was not avaliable in the database